1. OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab. (27th May 2021) Authors: Kennedy, N A; Goodhand, J; Bewshea, C; Nice, R; Chee, D; Lin, S; Chanchlani, N; Butterworth, J; Cooney, R; Croft, N; Hart, A; Irving, P; Kok, K; Lamb, C; Limdi, J; MacDonald, J; McGovern, D; Mehta, S; Murray, C; Patel, K Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S002 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P226 Dietary patterns differ in the newly diagnosed IBD cohort with ethnicity as a key confounding variable, a case control study. (30th January 2023) Authors: Dyall, L; Kyle, J; Misra, R; Clark, H; Limdi, J; Cooney, R; Brookes, M; Fogden, E; Pattni, S; Sharma, N; Iqbal, T; Munkholm, P; Burisch, J; Arebi, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P352 A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II. (27th May 2021) Authors: Lenti, M V; Dolby, V; Clark, T; Hall, V; Tattersall, S; Fairhurst, F; Kenneth, C; Walker, R; Kemp, K; Borg-Bartolo, S; Limdi, J; Taylor, J; Townsend, T; Subramanian, S; Storey, D; Assadsangabi, A; Stansfield, C; Smith, P; Byrne, D; De Silvestri, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P482 Safety and efficacy of ustekinumab for Crohn's disease in the elderly population. (27th May 2021) Authors: Fiske, J; Liu, E; Limdi, J; Conley, T E; Townsend, T; Davies, M; Brockwell, R; Baig, D; Abdelbadiee, S; Uney, A; Liaros, A; Gaba, W; Smith, P J; Subramanian, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P498 Ustekinumab Real World Evidence Study (UndieS): study design with information about positioning and the choice of ustekinumab. (30th January 2023) Authors: Young, D; Booker, C; Samaan, M; Limdi, J; Kok, K; Donovan, F; Hart, A; Smith, M; Bodger, K; Batchelor, J; Cummings, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P554 Vedolizumab Associated quality of Life and inflammatory bowel disease control Upon Entering a subcutaneous switching program (VALUE) – Results from a multi-centre UK study. (21st January 2022) Authors: Lim, S; Gros Alcade, B; Lehmann, A; Lindsay, J; Gaya, D; Caulfield, L; Dhar, A; Ritchie, S; Limdi, J; Taylor, J; Raine, T; Balendran, K; Shuttleworth, E; Kwok, J; Cococcia, S; Murray, C; Walker, G; Aldridge, R; George, B; Colbert, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P605 Real life efficacy of tofacitinib in different situation in ulcerative colitis: a retrospective worldwide multicentre collaborative study. (30th January 2023) Authors: Resál, T; Bacsur, P; Bor, R; Bálint, A; Katsanos, K; Michalopoylos, G; Ribaldone, D G; Attauabi, M; Mirabella, Z; Yanai, H; Bezzio, C; Castiglione, F; Bar-Gil Shitrit, A; Pugliese, D; Lakatos, P L; Savarino, E; Lukáš, M; Franko, M; Chashkova, E; Molander, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P729 A 'real-world' retrospective multi-centre study comparing infliximab and adalimumab for the maintenance of remission in ulcerative colitis. (16th January 2018) Authors: Kronsten, V; Colwill, M; Nayeemuddin, S; Limdi, J; Selinger, C; Scott, G; Al-Hillawi, L; Salehi, S; Blaker, P; Chung-Faye, G; Kent, A; Dubois, P; Hayee, B Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P863 Exploring patients' perceptions of clinical research in inflammatory bowel disease and barriers to participating in clinical trials. (30th January 2023) Authors: Chatten, K; Kalra, P; Bower, P; Mclaughlin, J; Ghosh, S; Limdi, J Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i986 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PTH-067 Incidental Diagnosis of Inflammatory Bowel Disease in A British Bowel Cancer Screening Cohort: 6-Year Clinical Outcome of The First Reported Cohort. (17th August 2016) Authors: Scott, J; Nosegbe, U; Butcher, R; Abbasi, A; Prudham, R; George, R; Limdi, J Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗